Symptoms and Common Misdiagnoses
At a Glance
ALSP is a rare, progressive brain white-matter disorder that can begin with changes in planning, behavior, language, or movement and may resemble MS, frontotemporal dementia, Alzheimer’s disease, or Parkinsonian disorders. Specialist evaluation and genetic testing can help clarify the diagnosis.
Because ALSP is so rare and its symptoms are so varied, it is frequently mistaken for more common neurological conditions. Research from specific cohorts shows that roughly 75.3% of patients are initially misdiagnosed [1]. For you and your family, understanding the specific ways ALSP manifests—and why it mimics other diseases—can help make sense of the confusing journey to a correct diagnosis.
The Common Domains of ALSP Symptoms
The symptoms of ALSP generally fall into four common domains. While many people eventually experience symptoms from several of these groups, the order in which they appear varies significantly, even between members of the same family, and not everyone develops symptoms in every domain [1][2].
1. Cognitive and Executive Dysfunction
For nearly half of patients in some studies (47.1%), cognitive changes are the first sign of the disease [1]. This isn’t just “forgetfulness”; it usually starts with executive dysfunction—difficulty with complex tasks like planning, organizing, or managing finances [3]. You may notice yourself or your loved one struggling to follow a recipe known for years or failing to keep track of appointments.
2. Psychiatric and Behavioral Changes
About 26.8% of patients first show symptoms that look like psychiatric issues [1]. These can include:
- Apathy: A profound loss of interest in hobbies, family, or work.
- Depression or Anxiety: Sudden changes in mood that don’t seem to have an external cause.
- Disinhibition: Acting impulsively or saying things that are socially inappropriate, which is often a sign of frontal lobe involvement [4].
3. Language Problems (Aphasia)
As the disease progresses, many patients develop aphasia—an impairment of language. In one study, 63% of patients experienced language difficulties [3]. This may start as mild “word-finding” pauses or progress to more significant difficulty communicating through speech. It does not necessarily mean a total inability to communicate, and speech therapy can help maximize communication strategies.
4. Motor and Movement Issues
Motor symptoms can appear early or late in the disease. These often include:
- Gait Disturbance: Changes in walking, such as shuffling, frequent tripping, or a loss of balance [3].
- Parkinsonism: This refers to symptoms that look like Parkinson’s disease, such as bradykinesia (slowness of movement), stiffness, or tremors [1].
- Pyramidal Signs: Weakness or stiffness in the limbs caused by damage to the nerve tracks that carry messages from the brain to the muscles [1].
Why Misdiagnosis is the Norm
Because ALSP symptoms overlap so heavily with other conditions, doctors often reach for the most common explanation first.
| If the primary symptom is… | The most common misdiagnosis is… | Why it is confused with ALSP |
|---|---|---|
| Cognitive & Behavioral | Frontotemporal Dementia (FTD) | Both cause early changes in personality and “executive” brain function in adults [4]. |
| White Matter Lesions | Multiple Sclerosis (MS) | Both show white spots on an MRI. However, while typical MS is characterized by inflammatory attacks that come and go, MS can also be progressive. Distinguishing between progressive MS and ALSP requires expert clinical evaluation, distinct MRI pattern recognition, and genetic testing [1]. |
| Memory Loss | Early-Onset Alzheimer’s | In some families, memory loss is more prominent than behavioral changes, mimicking Alzheimer’s [1]. |
| Movement Issues | Atypical Parkinson’s | The stiffness and slowness of ALSP can look identical to Parkinsonian syndromes [5]. |
| Vascular Changes | CADASIL | Both are genetic diseases of the white matter, but CADASIL is caused by blood vessel issues rather than immune cell (microglia) failure [1]. |
How the Disease Progresses
ALSP is generally a progressive disease, though its speed means something different for every person. On average, the disease duration (from onset to severe outcomes or death) in some published cohorts is about 6.8 years, but some patients have lived with the condition for up to 29 years [2].
In some patients, cognitive and daily living skills (like dressing or eating) may decline noticeably over a 24-month period once symptoms become apparent [3]. As the white matter continues to be lost and the brain experiences atrophy (shrinking), physical symptoms like swallowing difficulties (dysphagia) or seizures may emerge [3][1].
It is important to remember that these averages are just statistics from specific study groups, subject to survivor and referral bias. Some individuals remain stable for longer periods, while others may experience a faster decline. This variability is why specialized care and regular monitoring are essential.
Common questions in this guide
What symptoms are common in ALSP?
Why can ALSP be mistaken for multiple sclerosis?
What other conditions can look like ALSP?
How does ALSP usually progress?
Can speech therapy or physical therapy help with ALSP?
What helps doctors distinguish ALSP from other white-matter diseases?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given that many ALSP patients are initially told they have MS, what specific features of my MRI and clinical history distinguish this from MS?
- 2.I am experiencing some language trouble. Can we involve a speech-language pathologist early to help preserve communication strategies?
- 3.Are the movement issues we are seeing related to the white matter damage, and how can physical therapy help?
- 4.How do we track my specific symptoms over time without relying entirely on generic 'average' timelines?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (5)
- 1
Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies.
Papapetropoulos S, Gelfand JM, Konno T, et al.
Frontiers in neurology 2024; (15()):1320663 doi:10.3389/fneur.2024.1320663.
PMID: 38529036 - 2
Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.
Konno T, Yoshida K, Mizuno T, et al.
European journal of neurology 2017; (24(1)):37-45 doi:10.1111/ene.13125.
PMID: 27680516 - 3
Natural History of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): A Retrospective Patient Cohort Study.
Hayer SN, McLaren DG, Nance RM, et al.
Neurology and therapy 2026; (15(3)):1269-1292 doi:10.1007/s40120-026-00916-0.
PMID: 41915097 - 4
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD).
Adams SJ, Kirk A, Auer RN
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2018; (48()):42-49 doi:10.1016/j.jocn.2017.10.060.
PMID: 29122458 - 5
[Adult leukoencephalopathy with axonal spheroids and pigmented glia].
Rushkevich UN, Pavlovskaya TS, Levshuk ON, et al.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2025; (125(2)):130-136 doi:10.17116/jnevro2025125021130.
PMID: 40047845
This page explains ALSP symptoms, possible misdiagnoses, and disease progression for educational purposes only; it does not replace medical advice. A neurologist or other qualified clinician should interpret MRI findings, testing, and changes in function for your situation.
Get notified when new evidence is published on Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.